Fair enough. No harm done. There are a lot of factors up in the air and the situation is going to change as it moves along.
It seems to me that the fatality rate is somewhere around 2%. That is significant (if infection rates are maintained over time that equates to 10's of millions) and will have material impact over the coming months to years on most countries. Some will cope better than others (Iran being an example of the latter).
What is even more concerning is vast majority of people that catch the disease and spend 2 or more weeks (~4% of their year) recuperating with the commensurate strain on households and businesses. It seems the younger people will fair a bit better than their elders but the community based nature of the contagion will mean whole areas go partially offline either voluntarily or by mandate. Productivity losses will start to show as they have in China. Even if people are can work from home, they won't be as productive if they are sick and/or caring for others.
PME does give medical professionals the opportunity to remotely view and analyse information so hopefully that can help reduce risks to healthcare workers and increase productivity where it will be needed most.
Wash your hands and cough into your elbows everyone!
All IMO and DYOR.
PME Price at posting:
$20.60 Sentiment: Buy Disclosure: Held
(20min delay)